Biotech Growth N V - Net Worth and Insider Trading
Biotech Growth N V Net Worth
The estimated net worth of Biotech Growth N V is at least $242 Million dollars as of 2024-12-25. Biotech Growth N V is the 10% Owner of Radius Health Inc and owns about 6,881,685 shares of Radius Health Inc (RDUS) stock worth over $223 Million. Biotech Growth N V is the 10% Owner of Black Diamond Therapeutics Inc and owns about 8,517,839 shares of Black Diamond Therapeutics Inc (BDTX) stock worth over $19 Million. Biotech Growth N V is also the 10% Owner of ESSA Pharma Inc and owns about 0 shares of ESSA Pharma Inc (EPIX) stock worth over $0. Details can be seen in Biotech Growth N V's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Biotech Growth N V has not made any transactions after 2024-11-01 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Biotech Growth N V
Biotech Growth N V Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Biotech Growth N V owns 3 companies in total, including Radius Health Inc (RDUS) , ESSA Pharma Inc (EPIX) , and Black Diamond Therapeutics Inc (BDTX) .
Click here to see the complete history of Biotech Growth N V’s form 4 insider trades.
Insider Ownership Summary of Biotech Growth N V
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| RDUS | Radius Health Inc | 2019-11-06 | 10 percent owner |
| EPIX | ESSA Pharma Inc | 2024-11-01 | 10 percent owner |
| BDTX | Black Diamond Therapeutics Inc | 2023-10-17 | 10 percent owner |
Biotech Growth N V Latest Holdings Summary
Biotech Growth N V currently owns a total of 3 stocks. Among these stocks, Biotech Growth N V owns 6,881,685 shares of Radius Health Inc (RDUS) as of November 6, 2019, with a value of $223 Million and a weighting of 92.29%. Biotech Growth N V owns 8,517,839 shares of Black Diamond Therapeutics Inc (BDTX) as of October 17, 2023, with a value of $19 Million and a weighting of 7.71%. Biotech Growth N V also owns 0 shares of ESSA Pharma Inc (EPIX) as of November 1, 2024, with a value of $0 and a weighting of 0%.
Latest Holdings of Biotech Growth N V
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| RDUS | Radius Health Inc | 2019-11-06 | 6,881,685 | 32.47 | 223,448,312 |
| BDTX | Black Diamond Therapeutics Inc | 2023-10-17 | 8,517,839 | 2.19 | 18,654,067 |
| EPIX | ESSA Pharma Inc | 2024-11-01 | 0 | 1.61 | 0 |
Holding Weightings of Biotech Growth N V
Biotech Growth N V Form 4 Trading Tracker
According to the SEC Form 4 filings, Biotech Growth N V has made a total of 0 transactions in Radius Health Inc (RDUS) over the past 5 years. The most-recent trade in Radius Health Inc is the acquisition of 100,000 shares on November 6, 2019, which cost Biotech Growth N V around $2 Million.
According to the SEC Form 4 filings, Biotech Growth N V has made a total of 10 transactions in Black Diamond Therapeutics Inc (BDTX) over the past 5 years, including 10 buys and 0 sells. The most-recent trade in Black Diamond Therapeutics Inc is the acquisition of 400,000 shares on October 17, 2023, which cost Biotech Growth N V around $936,000.
According to the SEC Form 4 filings, Biotech Growth N V has made a total of 6 transactions in ESSA Pharma Inc (EPIX) over the past 5 years, including 4 buys and 2 sells. The most-recent trade in ESSA Pharma Inc is the sale of 7,879,583 shares on November 1, 2024, which brought Biotech Growth N V around $12 Million.
Insider Trading History of Biotech Growth N V
- 1
Biotech Growth N V Trading Performance
GuruFocus tracks the stock performance after each of Biotech Growth N V's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Biotech Growth N V is 6.64%. GuruFocus also compares Biotech Growth N V's trading performance to market benchmark return within the same time period. The performance of stocks bought by Biotech Growth N V within 3 months outperforms 29 times out of 60 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Biotech Growth N V's insider trading performs compared to the benchmark.
Performance of Biotech Growth N V
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -0.95 | | | | | |
| Relative Return to S&P 500(%) | -2.37 | | | | | |
Biotech Growth N V Ownership Network
Biotech Growth N V Owned Company Details
What does Radius Health Inc do?
Who are the key executives at Radius Health Inc?
Biotech Growth N V is the 10 percent owner of Radius Health Inc. Other key executives at Radius Health Inc include director & CEO and President G. Kelly Martin , Senior Vice President Elizabeth Messersmith , and Vice President & Sales Danielle Holtschlag .
Radius Health Inc (RDUS) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Radius Health Inc (RDUS) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Radius Health Inc (RDUS) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Radius Health Inc (RDUS)'s detailed insider trading history can be found in Insider Trading Tracker table.
Radius Health Inc Insider Transactions
Biotech Growth N V Mailing Address
Above is the net worth, insider trading, and ownership report for Biotech Growth N V. You might contact Biotech Growth N V via mailing address: Ara Hill Top Building, Unit A-5, Pletterijweg Oost 1, Curacao, Willemstad P8 000000.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
